The Company has filed an Application on 10th September, 2025 to BSE Limited for approval of reclassification from Promoter Group Shareholder Category to Public Shareholder category.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Ltd has applied to BSE on September 10, 2025, seeking approval to reclassify Ms. Shanta Somani from the 'Promoter Group Shareholder' category to the 'Public Shareholder' category under SEBI LODR Regulation 31A. Notably, Ms. Somani currently holds 0 shares (0%) in the company, making this a formal/cleanup reclassification rather than an active stake change. The application is awaiting BSE's approval. The company's Managing Director and CEO, Mr. Ruchit Mehta, signed the intimation.
This is largely an administrative housekeeping action with no actual change in shareholding, since the outgoing promoter group member holds zero shares. It should have no material impact on stock price or existing shareholders.